Authors: Vester, U Kranz, B Testa, G Malago, M Beelen, D Broelsch, CE Hoyer, PF

Citation: U. Vester et al., Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients, PEDIAT TRAN, 5(4), 2001, pp. 297-301

Authors: Lengfelder, E Reichert, A Schoch, C Haase, D Haferlach, T Loffler, H Staib, P Heyll, A Seifarth, W Saussele, S Fonatsch, C Gassmann, W Ludwig, WD Hochhaus, A Beelen, D Aul, C Sauerland, MC Heinecke, A Hehlmann, R Wormann, B Hiddemann, W Buchner, T

Citation: E. Lengfelder et al., Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1362-1370

Authors: Herget-Rosenthal, S Uppenkamp, M Beelen, D Kohl, D Kribben, A

Citation: S. Herget-rosenthal et al., Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation, NEPHRON, 84(2), 2000, pp. 136-141

Authors: Schulte, C Reinhardt, W Beelen, D Mann, K Schaefer, U

Citation: C. Schulte et al., Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation, BONE MAR TR, 22(12), 1998, pp. 1171-1178